Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 22 | 2024 | 99 | 10.030 |
Why?
|
| Tranexamic Acid | 15 | 2024 | 37 | 7.070 |
Why?
|
| Antifibrinolytic Agents | 14 | 2024 | 39 | 6.940 |
Why?
|
| Blood Coagulation Disorders | 6 | 2023 | 66 | 2.270 |
Why?
|
| Emergency Medical Services | 7 | 2024 | 238 | 2.160 |
Why?
|
| Glasgow Coma Scale | 7 | 2024 | 73 | 1.960 |
Why?
|
| Wounds and Injuries | 10 | 2024 | 259 | 1.760 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 2 | 2024 | 2 | 1.680 |
Why?
|
| Wounds, Nonpenetrating | 10 | 2023 | 113 | 1.590 |
Why?
|
| Intracranial Hemorrhages | 5 | 2024 | 130 | 1.500 |
Why?
|
| Wounds, Penetrating | 8 | 2019 | 57 | 1.310 |
Why?
|
| Fibrinolysis | 4 | 2023 | 37 | 1.170 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2024 | 59 | 1.140 |
Why?
|
| Biomarkers | 4 | 2024 | 1767 | 1.120 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2024 | 65 | 1.110 |
Why?
|
| Hemorrhage | 7 | 2024 | 280 | 1.070 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2024 | 184 | 1.040 |
Why?
|
| Infusions, Intraosseous | 1 | 2024 | 6 | 0.970 |
Why?
|
| Fibrinogen | 2 | 2021 | 53 | 0.890 |
Why?
|
| Brain Injuries | 5 | 2023 | 164 | 0.870 |
Why?
|
| Adult | 36 | 2024 | 26607 | 0.860 |
Why?
|
| Algorithms | 9 | 2018 | 1877 | 0.830 |
Why?
|
| Seizures | 1 | 2024 | 306 | 0.780 |
Why?
|
| Middle Aged | 26 | 2024 | 25974 | 0.760 |
Why?
|
| Syndecan-1 | 1 | 2020 | 16 | 0.730 |
Why?
|
| Angiopoietin-2 | 1 | 2020 | 17 | 0.730 |
Why?
|
| Disease Progression | 2 | 2024 | 1489 | 0.720 |
Why?
|
| Multiple Trauma | 4 | 2018 | 34 | 0.700 |
Why?
|
| Thrombelastography | 5 | 2021 | 47 | 0.690 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2024 | 2661 | 0.680 |
Why?
|
| Double-Blind Method | 6 | 2024 | 1719 | 0.670 |
Why?
|
| Young Adult | 15 | 2024 | 6312 | 0.660 |
Why?
|
| Blood Transfusion | 4 | 2013 | 169 | 0.640 |
Why?
|
| Male | 33 | 2024 | 42411 | 0.620 |
Why?
|
| Humans | 57 | 2024 | 89357 | 0.620 |
Why?
|
| Female | 34 | 2024 | 46202 | 0.610 |
Why?
|
| Injury Severity Score | 11 | 2024 | 143 | 0.600 |
Why?
|
| Thrombosis | 1 | 2019 | 302 | 0.560 |
Why?
|
| Isotonic Solutions | 1 | 2016 | 17 | 0.540 |
Why?
|
| Blood Coagulation | 3 | 2021 | 92 | 0.530 |
Why?
|
| Spleen | 1 | 2017 | 433 | 0.530 |
Why?
|
| Sodium Chloride | 1 | 2016 | 88 | 0.520 |
Why?
|
| International Normalized Ratio | 2 | 2014 | 39 | 0.510 |
Why?
|
| Ethanol | 1 | 2018 | 250 | 0.510 |
Why?
|
| Abdominal Injuries | 4 | 2018 | 46 | 0.480 |
Why?
|
| Infusions, Intravenous | 4 | 2024 | 435 | 0.460 |
Why?
|
| Trauma Centers | 7 | 2018 | 146 | 0.460 |
Why?
|
| Abbreviated Injury Scale | 4 | 2020 | 11 | 0.400 |
Why?
|
| Retrospective Studies | 16 | 2024 | 9057 | 0.400 |
Why?
|
| Blood Component Transfusion | 1 | 2011 | 13 | 0.390 |
Why?
|
| Traumatology | 3 | 2022 | 30 | 0.350 |
Why?
|
| Treatment Outcome | 11 | 2024 | 8241 | 0.340 |
Why?
|
| Survival Rate | 8 | 2024 | 1901 | 0.330 |
Why?
|
| Prospective Studies | 7 | 2021 | 4289 | 0.300 |
Why?
|
| Aged | 11 | 2021 | 19165 | 0.300 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 1723 | 0.290 |
Why?
|
| Emergency Service, Hospital | 4 | 2020 | 521 | 0.290 |
Why?
|
| Diaphragm | 2 | 2018 | 50 | 0.280 |
Why?
|
| Heart | 1 | 2010 | 574 | 0.280 |
Why?
|
| Thoracotomy | 2 | 2018 | 64 | 0.270 |
Why?
|
| Colon | 3 | 2019 | 510 | 0.270 |
Why?
|
| Wounds, Stab | 2 | 2018 | 10 | 0.260 |
Why?
|
| Thoracic Injuries | 2 | 2015 | 38 | 0.250 |
Why?
|
| Administration, Intravenous | 1 | 2024 | 57 | 0.240 |
Why?
|
| Intimate Partner Violence | 1 | 2024 | 28 | 0.220 |
Why?
|
| Clinical Decision-Making | 4 | 2018 | 281 | 0.220 |
Why?
|
| Time Factors | 4 | 2024 | 5338 | 0.220 |
Why?
|
| Firearms | 1 | 2024 | 69 | 0.210 |
Why?
|
| Cohort Studies | 2 | 2024 | 2872 | 0.210 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 114 | 0.210 |
Why?
|
| Head Injuries, Penetrating | 1 | 2023 | 55 | 0.200 |
Why?
|
| Mass Casualty Incidents | 1 | 2022 | 13 | 0.200 |
Why?
|
| Shock | 1 | 2022 | 44 | 0.200 |
Why?
|
| Adolescent | 5 | 2020 | 9263 | 0.200 |
Why?
|
| Suicide | 1 | 2024 | 151 | 0.200 |
Why?
|
| Erythrocyte Count | 2 | 2011 | 22 | 0.200 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 35 | 0.200 |
Why?
|
| Platelet Count | 2 | 2011 | 93 | 0.190 |
Why?
|
| Health Services Research | 1 | 2022 | 137 | 0.190 |
Why?
|
| Survival Analysis | 3 | 2020 | 1534 | 0.180 |
Why?
|
| Patient Acuity | 1 | 2020 | 33 | 0.180 |
Why?
|
| United States | 8 | 2024 | 6989 | 0.180 |
Why?
|
| Fracture Fixation | 2 | 2017 | 31 | 0.180 |
Why?
|
| Intracranial Pressure | 2 | 2023 | 87 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2020 | 186 | 0.160 |
Why?
|
| Peritoneum | 1 | 2019 | 57 | 0.160 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 43 | 0.160 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 505 | 0.160 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6811 | 0.150 |
Why?
|
| Rectum | 1 | 2018 | 148 | 0.150 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3666 | 0.150 |
Why?
|
| Occupational Exposure | 1 | 2018 | 87 | 0.140 |
Why?
|
| Rib Fractures | 1 | 2017 | 8 | 0.140 |
Why?
|
| Fever | 1 | 2018 | 128 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2017 | 157 | 0.140 |
Why?
|
| Pelvic Bones | 1 | 2016 | 43 | 0.140 |
Why?
|
| Duodenum | 1 | 2015 | 103 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2016 | 128 | 0.130 |
Why?
|
| Esophagus | 1 | 2015 | 106 | 0.130 |
Why?
|
| Logistic Models | 3 | 2012 | 1213 | 0.110 |
Why?
|
| Kidney | 1 | 2018 | 1147 | 0.110 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2012 | 30 | 0.100 |
Why?
|
| Enteral Nutrition | 1 | 2012 | 102 | 0.100 |
Why?
|
| Intestinal Obstruction | 1 | 2012 | 89 | 0.100 |
Why?
|
| Cerebral Hemorrhage | 1 | 2014 | 340 | 0.100 |
Why?
|
| Patient Selection | 1 | 2015 | 684 | 0.100 |
Why?
|
| Medical Futility | 1 | 2011 | 31 | 0.100 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2011 | 42 | 0.100 |
Why?
|
| Intestines | 2 | 2012 | 416 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2011 | 88 | 0.090 |
Why?
|
| Blood Volume Determination | 1 | 2010 | 14 | 0.090 |
Why?
|
| Registries | 1 | 2015 | 784 | 0.090 |
Why?
|
| Central Venous Pressure | 1 | 2010 | 26 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 159 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2010 | 51 | 0.090 |
Why?
|
| Cardiac Output | 1 | 2010 | 156 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2010 | 110 | 0.080 |
Why?
|
| Resuscitation | 3 | 2016 | 109 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 148 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 972 | 0.080 |
Why?
|
| Monitoring, Physiologic | 2 | 2023 | 266 | 0.080 |
Why?
|
| Tomography, Spiral Computed | 1 | 2009 | 77 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 253 | 0.080 |
Why?
|
| Sex Factors | 1 | 2011 | 1066 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 319 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2009 | 120 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2010 | 463 | 0.070 |
Why?
|
| Pancreas | 1 | 2009 | 246 | 0.070 |
Why?
|
| Laparotomy | 3 | 2012 | 67 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2009 | 227 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 605 | 0.070 |
Why?
|
| Hospital Mortality | 3 | 2013 | 387 | 0.070 |
Why?
|
| Risk Factors | 5 | 2018 | 5499 | 0.060 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 44 | 0.060 |
Why?
|
| Laparoscopy | 1 | 2011 | 773 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2019 | 273 | 0.060 |
Why?
|
| Decision Support Techniques | 2 | 2015 | 167 | 0.060 |
Why?
|
| Peripartum Period | 1 | 2024 | 30 | 0.060 |
Why?
|
| Homicide | 1 | 2024 | 46 | 0.060 |
Why?
|
| Colostomy | 2 | 2019 | 13 | 0.050 |
Why?
|
| Comparative Effectiveness Research | 1 | 2023 | 53 | 0.050 |
Why?
|
| Cecostomy | 1 | 2002 | 1 | 0.050 |
Why?
|
| Peritonitis | 2 | 2012 | 29 | 0.050 |
Why?
|
| Death | 1 | 2023 | 85 | 0.050 |
Why?
|
| Anus, Imperforate | 1 | 2002 | 11 | 0.050 |
Why?
|
| Tomography | 1 | 2022 | 21 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2022 | 24 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2022 | 32 | 0.050 |
Why?
|
| Violence | 1 | 2024 | 153 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2022 | 92 | 0.050 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2020 | 6 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2002 | 151 | 0.050 |
Why?
|
| Fibrinolysin | 1 | 2020 | 26 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 29 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1862 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2020 | 240 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2012 | 2303 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 1942 | 0.040 |
Why?
|
| Intestine, Small | 2 | 2012 | 299 | 0.040 |
Why?
|
| Incidence | 2 | 2015 | 1595 | 0.040 |
Why?
|
| Brain | 2 | 2023 | 2285 | 0.040 |
Why?
|
| Anticoagulants | 2 | 2012 | 427 | 0.040 |
Why?
|
| Hypotension | 1 | 2018 | 71 | 0.040 |
Why?
|
| Patient Admission | 1 | 2018 | 114 | 0.040 |
Why?
|
| Societies, Medical | 2 | 2012 | 575 | 0.040 |
Why?
|
| Research Design | 1 | 2022 | 599 | 0.040 |
Why?
|
| Hematoma | 1 | 2018 | 108 | 0.040 |
Why?
|
| Physical Examination | 1 | 2018 | 148 | 0.040 |
Why?
|
| Health Surveys | 1 | 2018 | 240 | 0.040 |
Why?
|
| Shock, Hemorrhagic | 1 | 2016 | 12 | 0.040 |
Why?
|
| Phenotype | 1 | 2023 | 2440 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 3018 | 0.030 |
Why?
|
| Health Personnel | 1 | 2018 | 215 | 0.030 |
Why?
|
| Practice Management | 1 | 2015 | 1 | 0.030 |
Why?
|
| Contrast Media | 2 | 2012 | 1091 | 0.030 |
Why?
|
| Pain Management | 1 | 2017 | 138 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2019 | 2284 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 51 | 0.030 |
Why?
|
| Critical Care | 1 | 2018 | 382 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 160 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 803 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2016 | 731 | 0.030 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2012 | 5 | 0.030 |
Why?
|
| Safety Management | 1 | 2012 | 56 | 0.030 |
Why?
|
| Peritoneal Lavage | 1 | 2011 | 12 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 433 | 0.020 |
Why?
|
| Hospitalization | 1 | 2018 | 877 | 0.020 |
Why?
|
| Case Management | 1 | 2011 | 25 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2012 | 82 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2015 | 279 | 0.020 |
Why?
|
| Oregon | 1 | 2011 | 26 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 661 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 856 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 851 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 712 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 231 | 0.020 |
Why?
|
| Abdomen | 1 | 2011 | 122 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2012 | 320 | 0.020 |
Why?
|
| Anastomotic Leak | 1 | 2011 | 103 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2011 | 127 | 0.020 |
Why?
|
| Aortography | 1 | 2009 | 65 | 0.020 |
Why?
|
| Wound Healing | 1 | 2011 | 359 | 0.020 |
Why?
|
| Pancreatic Ducts | 1 | 2009 | 28 | 0.020 |
Why?
|
| Low Back Pain | 1 | 2009 | 41 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 781 | 0.020 |
Why?
|
| Critical Illness | 1 | 2011 | 306 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2009 | 138 | 0.020 |
Why?
|
| Length of Stay | 1 | 2011 | 736 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 396 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 682 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2015 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1047 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 3783 | 0.010 |
Why?
|
| Enema | 1 | 2002 | 39 | 0.010 |
Why?
|
| Fecal Incontinence | 1 | 2002 | 57 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 3160 | 0.010 |
Why?
|